DR DOLLFus (France). I would like to ask Dr Watson which method he uses to control his therapy or preventive therapy by heparin? We start the prophylactic heparin I or 2 hours after injury, which is very soon according to certain people, but we've had no incidents and then we go along, we don't just give 5000 twice a day, but mostly we rely mainly on thrombo-elastogram. The thrombo-elastogram has shown an extraordinary thing, namely that suddenly you see it widening towards the loth and 15th day. Then we have to increase the doses of heparin, sometimes to nearly a curative dose and then go back to preventive doses. I wonder if Mr Watson has had such an experience. DR NORVAL WATSON (G.B.). Well, the question is easily answered because we don't do any testing at all. During the Warfarin we check the prothrombin times but we don't do any check on the heparins at all. It is not required. DR B. J. SUSSMAN (U.S.A.). I think I need some reassurance that in fact there are no complications in this therapy and of course it would be obvious that there were such complications if one had an incomplete cord injury and during this critical period of microvascular crisis with particular haemorrhages such a patient deteriorated; but then again the patient with the incomplete injury might not have a microvascular central grey effect, merely because of the lowest severity of his injury. How can I be reassured that the patient who is complete, the patient whom I think still has prospects of recovery by the adverse effects of this heparisation procedure, particularly if the attitude, in spite of your reassurance, is that you don't hold out much hopes for the prognosis in a complete lesion. I can see where easily the attitude might be, well the complete is probably going to remain complete and therefore the issue is clouded. DR MINAIRE (France). I would like just to add to Dr Frisbie's paper that there is in a middle-sized city about 550 miles from our place a gynaecologist who is against anti coagulants, I don't know why. He has used for years, maybe IS years, only passive range of motion in more than 2000 women who have delivered or had gynaecological surgery. He reported about 4 years ago at the French Congress of Obstetrics an inci dence of I per cent of deep vein thrombosis in these particular cases, just to add to Frisbie's paper. DR MEINECKE (Germany). How to detect the ratio of deep vein thrombosis and I would like to ask both speakers what kind of dye, in particular, did they use? DR NORVAL WATSON (G.B.). As far as Sheffield is concerned, we use a clinical diagnosis, confirmed or refuted by the sonic aid apparatus, a clinical method only.
DR FRISBIE (U.S.A.). At the West Roxbury Veterans Administration Hospital we did use both methods. We did not report the radioactive fibrinogen light-scanning data because they weren't done on all patients also because it is an extremely sensitive technique and in our previous experience with spinal cord injury patients at least we were finding thrombosis that we could not detect phenographically. So with the idea that the platysmograph being a coarser measure of deep venous thrombosis would be a more suitable test. The light-scan data though did show that we had as many deep venous thromboses in the heparin treatment group as we had in the non-heparin treatment group. The platysmographic technique is not as widely used as the light-scanning technique but I felt that it probably is very useful on an emergency basis because you can get an answer the same day, whereas light-scanning technique takes 24 hours. Dr Rossier presented the first paper 2 years ago and I think he mentioned how the IPG or the impedence platysmograph worked. It is simply a measure of flow through the veins of the lower extremities and when this flow is interrupted we can detect the interruption in the flow and imply a venous thrombosis. This interruption of flow occurs only with the large venous thrombosis and on venography you will find a thombus proximal to the popliteal vein which would have a positive in the platysmographic test. A cuff which is put around the thigh and the change in the electrical conductlmce in the calf is measured as the blood collects in the calf. This change of conductance is measured in its first curves, the cuff is then deflated, the blood rushes out and the change in conductance is again recorded there. This is a normal platysmographic test. In the case of a clot this curve is critical, it would be sloped instead of stretched out. We have a calibration method to show when the change in the slope is significant. DR J. SILVER (G.B.). I must be suffering under a lot of misapprehensions. In Dr Frisbie's paper or Dr Rossier's, the first slide said that you were only admitting patients to the trial with deep venous thrombosis. Was that a mistake on the slide or am I going senile and couldn't read the slide properly? DR FRISBIE. We excluded patients who had been admitted with deep venous thrombosis so we took only those patients who had no deep venous thrombosis at the time when they were admitted.
DR SILVER. The slide said that you took the patients with deep venous thrombosis. DR FRISBIE. That was a mistake. DR SILVER. That was a mistake on the slide, right. Now the next question I would like to ask is, I understood from Sebbert's work, 'Fractured necks of femur', when he started the anti-coagulation on the universal population at the Birmingham Accident Hospital, that a third of the deep venous thrombosis arose in the pelvic veins. Now the techniques you described did not estimate the incidence of deep venous thombosis above the popliteal region. Did you make any venography studies to estimate the incidence in the pelvis?
DR FRISBIE. Well, we only had two cases of deep venous thrombosis in the later study and one of these was studied venographically and the thrombus was not in the pelvic vein. I think venography is the only way you could ever tell. Even in the impe dence platysmographic test we missed a pelvic vein thrombosis.
DR SILVER. Well, that is the point I am making. DR FRISBIE. We have had some experience with the light scan where we've been able to pick up or show fibrin uptake in the thigh and even over the umbilicus so we have some informal evidence that the thrombus does start high up. DR GRIFF ITHS (Australia). Just a brief one to Dr Watson, since visiting Alan Hardy there about 4 years ago, we've tried the low-dose heparin since 74, 75 and 76 and I regret to say it doesn't seem to have made much difference at all in the incidence of deep venous thrombosis, not in our cases anyway. We've given it to all complete cases in the dosage of 5000 subcutaneous twice daily for a period of 4 weeks to 5 weeks after admission, we've had no incidence of haemorrhage resulting from it but we've had no decrease of the in cidence of deep venous thrombosis. I haven't got the exact figures to give you but I'm afraid I can't support Dr Watson's impression that this is the answer to all deep venous thrombosis.
